Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Parkinson's disease Stories

2013-10-04 16:21:57

NEW YORK, Oct. 4, 2013 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has created think/able: Miles for a Cure, calling on the Parkinson's community to walk, run, or bike a collective 50,000 miles to raise funds for research. For 30 days only, medical technology company Medtronic will match miles tracked through the Charity Miles smartphone application (app) with dollars up to $50,000. "Miles for a Cure offers a great way for our community to...

2013-10-03 23:37:08

Understanding Essential Tremor: The Diagnosis Process and Treatment Options Lenexa, KS (PRWEB) October 03, 2013 The International Essential Tremor Foundation (IETF) will host a free seminar in Des Moines, Iowa on the life-altering neurological condition called essential tremor (ET). The seminar will take place on Thursday, October 17, 2013 at the Mercy Medical Center in the East Tower Auditorium located at 1111 6th Avenue in Des Moines, Iowa. The program will run from 6:30 to 8:30 p.m.,...

2013-10-03 16:23:03

NEW BRUNSWICK, N.J., Oct. 3, 2013 /PRNewswire-USNewswire/ -- Research being performed by Durin Technologies, Inc., exploring the development of a novel blood test for Parkinson's disease was recently awarded a second grant from The Michael J. Fox Foundation for Parkinson's Research. Durin, a company that received seed funding from Foundation Venture Capital Group, LLC, developed the test that could mean quicker diagnosis and faster drug development for Parkinson's patients. "Using current...

2013-10-03 12:26:34

- Posters presented on the Parkinson's More Than Motion(TM) community and the Parkinson's Well-Being Map(TM) MONTREAL, Oct. 3, 2013 /PRNewswire/ -- UCB today announced two poster presentations at the 2013 World Parkinson Congress (WPC) highlighting key Parkinson's disease (PD) patient support programs aimed at providing educational support through social media and other tools. The WPC is being held at the Palais des Congres in Montreal, Canada, October 1-4, 2013. Abstract title: The social...

Depression Linked To Elevated Parkinson's Risk
2013-10-03 11:38:00

Brett Smith for redOrbit.com - Your Universe Online Affecting about 1 in 500 individuals, Parkinson’s disease is a neurodegenerative condition marked by physical shaking or stiffness, and new research published in the journal Neurology has found a connection between depression and increased risk for the disease. In the study, a team of Taiwanese researchers followed over 22,000 adults for a decade and discovered that people diagnosed with depression were over three times more likely...

2013-10-03 08:29:30

-- Brings Omeros' Total to 52 Class A Orphans and Opens Way to New Oral Drugs to Treat Diabetes and Osteoporosis -- SEATTLE, Oct. 3, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has identified compounds that functionally interact with each of six additional orphan G protein-coupled receptors (GPCRs) that have been linked to a wide range of diseases in the areas of neurologic disorders, cardiovascular disease and oncology. Identification of...

2013-10-02 23:35:10

Understanding Essential Tremor: The Diagnosis Process and Treatment Options Lenexa, KS (PRWEB) October 02, 2013 The International Essential Tremor Foundation (IETF) will host a free seminar in Suffern, N.Y. on the life-altering neurological condition called essential tremor (ET). The seminar will take place on Saturday, October 12, 2013 at the Crowne Plaza Hotel located at 3 Executive Blvd. in Suffern, N.Y. The program will run from 9:30 to 11:30 a.m., with a question and answer session...

2013-10-02 12:51:46

Results presented at World Parkinson Congress Researchers at the University of Montreal and the Institut universitaire de gératrie de Montréal examined brain changes over 20 months in Parkinson's patients with and without mild cognitive impairment (MCI) at the early stages of the disease. Results showed that patients with MCI had significantly more cortical thinning and subcortical atrophy over time compared with patients without MCI, suggesting that early MCI in PD patients may indicate...

2013-10-02 12:29:35

Results from the Phase 2/3 EASED Trial Demonstrate an Increase of Approximately Three Hours in ON Time Without Troublesome Dyskinesia for Patients Taking ADS-5102 Compared to Placebo MONTREAL and EMERYVILLE, Calif., Oct. 2, 2013 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. presented positive results today from the Phase 2/3 EASED((TM)) clinical trial of ADS-5102 at the World Parkinson's Congress. ADS-5102 is Adamas' proprietary long-acting capsule formulation of amantadine HCl in development...

2013-09-30 16:23:39

PHOENIX, Sept. 30, 2013 /PRNewswire/ -- Millions around the nation recently watched the NBC premier of "The Michael J. Fox Show." Leading experts at the Muhammad Ali Parkinson Center in Phoenix say they are delighted to see national exposure for this often misunderstood disease. The new television series stars Michael J. Fox as a news anchor who returns to work five years after being diagnosed with Parkinson's disease, which affects as many as 1.5 million Americans. "Our...